EO 14398 FY26 ebola atovaquone proguanil

Ended Awarded Last action

Contract number
75D30126F21661
Awardee
Awarding agency
Obligated
$58,155

Award facts

Contract value 100% obligated
$58,155.45 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Atlanta, GA 30329, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 -$16,744
Original award $74,900

About this award

The Centers for Disease Control and Prevention Pittsburgh issued a $58,155.45 delivery order to Glaxosmithkline, LLC on September 22, 2026, for atovaquone and proguanil under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with completion by September 30, 2026.

Place of performance is Atlanta, GA. The order is priced firm fixed and carries no set-aside.

Quick answers

Who was awarded contract 75D30126F21661?

75D30126F21661 was awarded to Glaxosmithkline, LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 22, 2026.

How much is contract 75D30126F21661 worth?

The government has obligated $58,155 on 75D30126F21661.

Is contract 75D30126F21661 an order under another contract?

Yes. 75D30126F21661 is a delivery order under 36F79722D0178, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 75D30126F21661 competed?

The extent of competition for 75D30126F21661 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award